Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-12, with 43 holding rows worth $181,752,000.

Accession
0001420506-21-001557
Filed
2021-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 43 entries on the cover page, a total value of $181,752,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $181,752,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PROTHENA CORP PLC SHSG72800108Stock323,300$23,029,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK445,020$13,885,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR250,680$13,188,000thousands by filing date
CUE BIOPHARMA INC22978P106COM655,185$9,546,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW153,400$9,135,000thousands by filing date
ZOGENIX INC.98978L204Common Stock490,882$7,456,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM274,761$6,776,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM735,000$6,453,000thousands by filing date
CONVEY HEALTH SOLUTIONS HLDG21258C108CMN738,012$6,199,000thousands by filing date
EXICURE INC30205M101COM5,125,000$6,150,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM629,957$5,443,000thousands by filing date
GALAPAGOS NV36315X901SPON ADR100,000$5,261,000thousands by filing datecall
KALVISTA PHARMACEUTICALS INC483497103COM257,391$4,491,000thousands by filing date
ACCOLADE INC00437E102COM97,988$4,132,000thousands by filing date
MORPHIC HLDG INC61775R105COM70,000$3,965,000thousands by filing date
METACRINE INC59101E103COM1,145,034$3,927,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK291,080$3,836,000thousands by filing date
HUMANA INC COM444859102Stock9,000$3,502,000thousands by filing date
SHATTUCK LABS INC82024L103COMMON STOCK169,241$3,449,000thousands by filing date
OSCAR HEALTH INC687793109CL A188,400$3,276,000thousands by filing date
PROGYNY INC74340E953PUT55,000$3,080,000thousands by filing dateput
AMEDISYS INC023436108COM20,000$2,982,000thousands by filing date
AGILON HEALTH INC00857U107COM109,510$2,870,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM15,000$2,721,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock38,319$2,705,000thousands by filing date
AbbVie,Inc.00287Y109COM24,800$2,675,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260900COM100,000$2,466,000thousands by filing datecall
ENCOMPASS HEALTH CORP COM29261A100Stock31,647$2,375,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO282,256$2,362,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock37,396$2,190,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock13,000$1,903,000thousands by filing date
PANACEA ACQUISITION CORP IIG6882C106COM188,940$1,846,000thousands by filing date
WATERS CORP COM941848103Stock4,000$1,429,000thousands by filing date
UnitedHealth Group Inc91324P102COM3,300$1,289,000thousands by filing date
CELLECTIS ADS15117K103COM87,103$1,098,000thousands by filing date
SIO GENE THERAPIES INC829399104COM493,208$1,070,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM265,634$924,000thousands by filing date
ALECTOR INC014442107COMMON STOCK27,378$625,000thousands by filing date
LIFESTANCE HEALTH GROUP INC53228F101COM38,774$562,000thousands by filing date
ORGANOGENESIS HOLDINGS INC68621F102COMMON STOCK38,000$541,000thousands by filing date
ONCORUS INC68236R103COM55,411$518,000thousands by filing date
MIMEDX GROUP INC602496101COM44,225$268,000thousands by filing date
APTOSE BIOSCIENCES INC COM03835T200Stock70,563$154,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-21-001557this filing2021-11-12acceptance time not in the bulk data set